LEMAITRE VASCULAR, INC. Operating Lease Cost
LEMAITRE VASCULAR, INC. (LMAT) reported Operating Lease Cost of $1.32 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-05
- LEMAITRE VASCULAR, INC. operating lease, cost for the quarter ending 2026-06-30 was $1.32M, a 196.42% increase year-over-year.
- LEMAITRE VASCULAR, INC. operating lease, cost for the quarter ending 2026-03-31 was $1.34M, a 125.46% increase year-over-year.
- LEMAITRE VASCULAR, INC. operating lease, cost for the quarter ending 2025-12-31 was $1.92M, a 100.31% increase year-over-year.
- LEMAITRE VASCULAR, INC. operating lease, cost for the quarter ending 2025-09-30 was $690.00K, a 41.68% increase year-over-year.
- LEMAITRE VASCULAR, INC. operating lease, cost for fiscal 2025 was $3.65M, a 26.15% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. operating lease, cost for fiscal 2024 was $2.90M, a 19.63% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. operating lease, cost for fiscal 2023 was $2.42M, a 9.85% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. operating lease, cost for fiscal 2022 was $2.20M, a 3.16% decline from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 6 month as first filed | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.32M 10-Q · filed 2026-08-05 | $2.66M 10-Q · filed 2026-08-05 | $4.58M derived: sum of 3 quarters · filed 2026-08-05 | $5.27M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $1.34M 10-Q · filed 2026-05-06 | $3.26M derived: sum of 2 quarters · filed 2026-05-06 | $3.95M derived: sum of 3 quarters · filed 2026-05-06 | $4.39M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.61M derived: sum of 2 quarters · filed 2026-02-26 | $3.06M derived: sum of 3 quarters · filed 2026-08-05 | $3.65M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $690.00K 10-Q · filed 2025-11-07 | $1.14M derived: sum of 2 quarters · filed 2026-08-05 | $1.73M 10-Q · filed 2025-11-07 | $2.69M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $447.00K 10-Q · filed 2026-08-05 | $1.04M 10-Q · filed 2026-08-05 | $2.00M derived: sum of 3 quarters · filed 2026-08-05 | $2.49M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $593.00K 10-Q · filed 2026-05-06 | $1.55M derived: sum of 2 quarters · filed 2026-05-06 | $2.04M derived: sum of 3 quarters · filed 2026-05-06 | $2.75M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $959.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.45M derived: sum of 2 quarters · filed 2026-02-26 | $2.15M derived: sum of 3 quarters · filed 2026-02-26 | $2.90M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $487.00K 10-Q · filed 2025-11-07 | $1.20M derived: sum of 2 quarters · filed 2025-11-07 | $1.94M 10-Q · filed 2025-11-07 | $2.42M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | $709.00K 10-Q · filed 2025-08-06 | $1.15M 10-Q · filed 2025-08-06 | $1.45M 10-Q · filed 2024-08-08 | $1.93M derived: sum of 3 quarters · filed 2025-08-06 | $2.73M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $740.00K 10-Q · filed 2025-05-08 | $1.22M derived: sum of 2 quarters · filed 2025-05-08 | $2.02M derived: sum of 3 quarters · filed 2025-05-08 | $2.58M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $479.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.28M derived: sum of 2 quarters · filed 2025-02-28 | $1.84M derived: sum of 3 quarters · filed 2025-02-28 | $2.42M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $797.00K 10-Q · filed 2024-11-08 | $1.36M derived: sum of 2 quarters · filed 2024-11-08 | $1.94M 10-Q · filed 2024-11-08 | $2.19M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $564.00K 10-Q · filed 2024-08-08 | $1.14M 10-Q · filed 2024-08-08 | $1.39M derived: sum of 3 quarters · filed 2024-08-08 | $2.18M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $580.00K 10-Q · filed 2024-05-10 | $828.00K derived: sum of 2 quarters · filed 2024-05-10 | $1.62M derived: sum of 3 quarters · filed 2024-05-10 | $2.26M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | $248.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.04M derived: sum of 2 quarters · filed 2024-02-29 | $1.68M derived: sum of 3 quarters · filed 2024-02-29 | $2.20M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $792.00K 10-Q · filed 2023-11-07 | $1.43M derived: sum of 2 quarters · filed 2023-11-07 | $1.96M 10-Q · filed 2023-11-07 | $2.55M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $638.00K 10-Q · filed 2023-08-08 | $1.16M 10-Q · filed 2023-08-08 | $1.76M derived: sum of 3 quarters · filed 2023-08-08 | $2.34M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $525.00K 10-Q · filed 2023-05-09 | $1.12M derived: sum of 2 quarters · filed 2023-05-09 | $1.71M derived: sum of 3 quarters · filed 2023-05-09 | $2.19M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $593.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.18M derived: sum of 2 quarters · filed 2023-03-01 | $1.67M derived: sum of 3 quarters · filed 2023-03-01 | $2.27M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $588.00K 10-Q · filed 2022-11-08 | $1.07M derived: sum of 2 quarters · filed 2022-11-08 | $1.68M 10-Q · filed 2022-11-08 | $2.18M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | $487.00K 10-Q · filed 2022-08-05 | $1.09M 10-Q · filed 2022-08-05 | $1.59M derived: sum of 3 quarters · filed 2022-08-05 | $2.05M derived: sum of 4 quarters · filed 2022-08-05 | |
| 2021-03-31 | $607.00K 10-Q · filed 2022-05-10 | $1.11M derived: sum of 2 quarters · filed 2022-05-10 | $1.56M derived: sum of 3 quarters · filed 2022-05-10 | $2.04M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | $499.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $956.00K derived: sum of 2 quarters · filed 2022-02-28 | $1.44M derived: sum of 3 quarters · filed 2022-02-28 | $1.91M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $457.00K 10-Q · filed 2021-11-04 | $938.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.41M 10-Q · filed 2021-11-04 | $1.83M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | $481.00K 10-Q · filed 2021-08-05 | $955.00K 10-Q · filed 2021-08-05 | $1.37M derived: sum of 3 quarters · filed 2021-08-05 | $1.86M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $474.00K 10-Q · filed 2021-05-10 | $890.00K derived: sum of 2 quarters · filed 2021-05-10 | $1.38M derived: sum of 3 quarters · filed 2021-05-10 | $1.81M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | $416.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $902.00K derived: sum of 2 quarters · filed 2021-03-12 | $1.33M derived: sum of 3 quarters · filed 2021-03-12 | $1.76M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $486.00K 10-Q · filed 2020-11-06 | $918.00K derived: sum of 2 quarters · filed 2020-11-06 | $1.34M 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $432.00K 10-Q · filed 2020-08-06 | $854.00K 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $422.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |